Timber Hill’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,000
Closed -$675K 379
2017
Q4
$675K Sell
3,000
-8,000
-73% -$1.7M 0.04% 351
2017
Q3
$2.09M Sell
11,000
-9,900
-47% -$1.88M 0.19% 92
2017
Q2
$3.93M Sell
20,900
-2,000
-9% -$359K 0.15% 103
2017
Q1
$3.79M Sell
22,900
-24,900
-52% -$3.96M 0.03% 452
2016
Q4
$6.87M Sell
47,800
-20,900
-30% -$2.8M 0.03% 418
2016
Q3
$8.61M Sell
68,700
-44,000
-39% -$5.68M 0.04% 337
2016
Q2
$14.8M Buy
112,700
+54,700
+94% +$7.48M 0.07% 238
2016
Q1
$8.06M Sell
58,000
-8,700
-13% -$1.16M 0.04% 373
2015
Q4
$9.3M Buy
66,700
+17,300
+35% +$2.38M 0.05% 338
2015
Q3
$6.92M Sell
49,400
-30,600
-38% -$4.6M 0.03% 441
2015
Q2
$13.1M Buy
80,000
+29,400
+58% +$4.7M 0.06% 277
2015
Q1
$7.81M Sell
50,600
-50,200
-50% -$7.15M 0.04% 405
2014
Q4
$12.7M Buy
100,800
+19,900
+25% +$2.46M 0.05% 284
2014
Q3
$9.68M Buy
80,900
+30,200
+60% +$3.46M 0.04% 359
2014
Q2
$5.46M Sell
50,700
-90,100
-64% -$9.28M 0.02% 576
2014
Q1
$14M Buy
140,800
+22,300
+19% +$2.02M 0.06% 261
2013
Q4
$10.9M Sell
118,500
-148,300
-56% -$13.2M 0.04% 384
2013
Q3
$22.3M Sell
266,800
-2,100
-0.8% -$180K 0.08% 207
2013
Q2
$22M Buy
+268,900
New +$20.1M 0.08% 199

Other funds holding ELV

Timber Hill's ELV Position: Q2 2018 in Review

Timber Hill sold out of Elevance Health (ELV) in Q2 2018, closing a stake of 4,096 shares — an estimated $900K sold.

Timber Hill first reported a position in ELV in Q3 2013 and held it in 9 quarters. The position peaked at $3.87M in Q4 2016. 934 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

  • Timber Hill reported no remaining Elevance Health position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 4,096 Elevance Health shares in Q2 2018, an estimated $900K.
  • Timber Hill first reported a position in Elevance Health in Q3 2013 and held it in 9 quarters.
  • Timber Hill's Elevance Health position peaked at $3.87M in Q4 2016.
  • 934 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.